https://www.selleckchem.com/pr....oducts/pyridostatin-
8%; center-level range 0.9-3.8%) of included patients (median age 55 (IQR 34-76), 84% Caucasian, 60% male, 92% blunt, median ISS 9 (IQR5-16)). Death after CC occurred in 982/5,097 patients for an FTR-C rate of 19.3% (center-level range 7.8-30.4%). 10/27 centers were high-performers (95% confidence interval for OE ratio less then 1) for CC and 2/27 centers were high-performers for FTR-C, but internal consistency between these metrics was poor (alpha = 0.31). CONCLUSION Rates of CC and FTR-C vary significantly b
Like
Comment
Share
